International Flavors & Fragrances Inc.
NYSE•IFF
CEO: Dr. Jennifer Amy Johnson Ph.D.
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 1974-12-17
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products. It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
Contact Information
Market Cap
$16.75B
P/E (TTM)
-40.6
18.9
Dividend Yield
2.4%
52W High
$88.09
52W Low
$59.14
52W Range
Rank49Top 53.8%
3.6
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 3.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$2.69B-7.90%
4-Quarter Trend
EPS
$0.16-30.44%
4-Quarter Trend
FCF
$30.00M-88.37%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Q3 Sales Decline Reported Net sales totaled $2.694 B in Q3 2025, down 8% reported, driven by divestitures impacting portfolio mix.
Gross Margin Expansion Noted Q3 Gross margin improved 50 basis points to 36.5% of sales, supported by favorable net pricing and productivity gains.
Major Goodwill Impairment Nine months included $1.153 B goodwill impairment charge for Food Ingredients reporting unit following reorganization.
Significant Debt Reduction Total debt reduced to $6.049 B by September 30, 2025, including $488 M gain from debt extinguishment.
Risk Factors
Substantial Net Loss Reported Net loss attributable to shareholders was $(392) M for Q3 2025, resulting in diluted EPS of $(1.53).
Asset Held for Sale Loss Recorded $108 M impairment loss on SCL disposal group assets classified as held for sale during the third quarter.
Litigation Provision Recorded Provision of $43.25 M recognized for U.S. class action lawsuits, impacting Selling and Administrative Expenses.
Productivity Program Costs Restructuring charges increased to $54 M YTD due to higher severance costs related to the IFF Productivity Program.
Outlook
Segment Structure Reorganization Implemented new segment structure January 1, 2025, separating Nourish into Taste and Food Ingredients for clarity.
Productivity Program Completion Productivity enhancement program aims for substantial completion by December 31, 2026, with estimated costs up to $120 M.
Capital Strategy Focus Strategy prioritizes maintaining investment grade ratings, paying dividends, repurchasing shares, and repaying outstanding debt.
Hedging Capacity Expanded Entered agreements October 1, 2025, expanding cross currency swap capacity by $500 million notional value.
Peer Comparison
Revenue (TTM)
PKX$49.83B
DOW$40.91B
LYB$32.56B
Gross Margin (Latest Quarter)
42.3%
CF38.1%
36.5%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| SQM | $19.34B | 40.1 | 9.2% | 40.2% |
| PAAS | $18.35B | 34.7 | 10.9% | 11.2% |
| CX | $16.77B | 11.2 | 11.9% | 10.6% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-0.9%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Feb 17, 2026
EPS:$0.85
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 4, 2025|Revenue: $2.69B-7.9%|EPS: $0.16-30.4%MissForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Aug 5, 2025|Revenue: $2.76B-4.3%|EPS: $2.39+256.7%BeatForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 6, 2025|Revenue: $2.84B-1.9%|EPS: $-3.98-1758.3%MissForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Feb 28, 2025|Revenue: $11.48B+0.0%|EPS: $0.95+109.4%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 5, 2024|Revenue: $2.93B+3.7%|EPS: $0.23+134.7%MissForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 6, 2024|Revenue: $2.89B-1.4%|EPS: $0.67+509.1%MissForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: May 6, 2024|Revenue: $2.90B-4.2%|EPS: $0.24-864.3%MissForm 10-K - FY 2023
Period End: Dec 31, 2023|Filed: Feb 28, 2024|Revenue: $11.48B-7.7%|EPS: $-10.06-39.7%Miss